Incidence of tuberculous and non-tuberculous mycobacteria, differentiated by multiplex PCR, in clinical specimens of a large general hospital by Bensi, Eliane Picoli Alves et al.
Incidence of tuberculous and non-tuberculous myco-
bacteria, differentiated by multiplex PCR, in clinical
specimens of a large general hospital
Eliane Picoli Alves Bensi,I Patricia Costa Panunto,I Marcelo de Carvalho RamosII
IUniversity of Campinas, Faculty of Medical Sciences, (FCM/UNICAMP), Clinical Laboratory, Campinas/SP, Brazil. IIUniversity of Campinas (UNICAMP),
Faculty of Medical Sciences, Infectology, Campinas/SP, Brazil.
OBJECTIVE: To determine the incidence of Mycobacterium tuberculosis complex and non-tuberculous
mycobacterial isolates in the routine setting of a large general hospital using an "in-house" multiplex
polymerase chain reaction method and to establish a paradigm for the definitive identification of mycobacteria
isolated using semi-automated equipment.
METHODS: Established tests, including polymerase chain reaction restriction enzyme analysis, PNB, and NAP
inhibition tests as the gold standard, showed 100% agreement with an IS6110/hsp65 multiplex polymerase
chain reaction when used to identify stock strains (n =117).
RESULTS: In a subsequent study, 8,790 clinical specimens producing 476 isolates were evaluated with multiplex
PCR and also showed 100% agreement in identification using PRA-polymerase chain reaction as the gold
standard. The application of this technique to routine analysis was demonstrated in this study. A method was
established with the initial application of multiplex PCR for all positive liquid cultures and the subsequent
identification of non-tuberculous mycobacteria by polymerase chain reaction restriction enzyme analysis. In
total, 77% of isolates belonged to the Mycobacterium tuberculosis complex, and 23% were non-tuberculous
mycobacteria.
CONCLUSIONS: Several non-tuberculous mycobacterial species were identified, primarily M. avium, but other
potentially pathogenic species were also frequently observed, including M. fortuitum, M. abscessus, and M.
kansasii. The expeditious communication of these data to the clinical staff was fundamental for the diagnosis of
clinical cases. Even in settings where tuberculosis is of major importance, the incidence of non-tuberculous
mycobacteria infection is substantial.
KEYWORDS: Non-tuberculous Mycobacterial Infections; Tuberculosis; Microbiological Techniques.
Bensi EP, Panunto PC, Ramos MC. Incidence of tuberculous and non-tuberculous mycobacteria, differentiated by multiplex PCR, in clinical
specimens of a large general hospital. Clinics. 2013;68(2):179-183.
Received for publication on September 5, 2012; First review completed on September 14, 2012; Accepted for publication on October 22, 2012
E-mail: mdecr@unicamp.br
Tel.: 55 19 3521-7423
& INTRODUCTION
Mycobacterial infections are among the leading causes of
disease in humans. In developing countries, the high
incidence of tuberculosis overshadows the occurrence of
non-tuberculous mycobacterial (NTM) infections, although
this picture is changing. The incidence of NTM infections is
increasing as a result of several conditions, such as the
growing number of immunodeficient patients (1), the use of
contaminated endoscopic medical devices, and cosmetic
procedures (2). The correct identification of Mycobacterium is
the mainstay for the clinical management of these patients.
The currently available commercial molecular biology
tests designed for the direct identification of mycobacteria
from clinical specimens have been employed (3-5), but they
carry economic and methodological limitations.
Culture-based methods remain the gold standard for the
specific diagnosis of these infections. Although Mycobacterium
is readily isolated in solid or liquid media, the correct
identification of the specimen is laborious and time consuming.
There are few licensed assays that can accurately and quickly
identify mycobacteria. The commercially available AccuProbe
assay (Gene Probe, San Diego, California) and the polymerase
chain reaction (PCR)-based reverse hybridization Inno-LiPA
assay (Innogenetics, Ghent, Belgium) (6) are expensive and
difficult to employ in resource-limited institutions.
Recently, PCR and PCR-linked in-house methods have
been used for the rapid detection and differentiation of
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MTC and NTM in routine diagnostic laboratories. Multiplex
PCR, which targets many different genes simultaneously,
has been used for this goal (7-12). The incidence of MTC and
NTM was determined in this work using an ‘‘in-house’’
method targeting a specific sequence in MTC organisms
(IS6110) and the hsp65 gene found in both MTC and NTM.
A method could thus be established with the initial
definitive identification of the isolate using multiplex PCR
followed by PRA-PCR as the standard species-level identi-
fication test.
& MATERIALS AND METHODS
The study was performed at the Molecular Biology and
Bacterial Pathogenesis Laboratory of the Clinical Medical
Department in the Faculty of Medical Sciences in the State
University of Campinas (Brazil). This study comprised two
distinct studies. The first was designed to compare a simple
PCR-based identification test (hsp65/IS6110 multiplex PCR)
with reference tests (PNB and NAP) using a set of
previously identified MTC and NTM strains. The second
was intended to identify mycobacteria grown with the aid
of a semi-automated culture system (MGIT 960) in the
routine setting of a clinical laboratory using the previously
tested hsp65/IS6110 multiplex PCR. PRA-PCR was used as
the gold standard for both parts of the study.
Mycobacterial Strains
Study one – Stock strains that were previously identified
by PRA-PCR and recovered from clinical specimens
obtained from patients who were previously admitted to
the hospital were as follows: M. tuberculosis (n = 91), M.
abscessus (n = 2), M. avium (n = 6), M. gordonae (n = 13), and
other NTM (n = 2). The strains were preserved in
Lowenstein-Jensen (LJ) media and transferred to MGIT
bottles or fresh Lowenstein-Jensen media for further tests.
Study two – The study was designed to last from January
2009 until July 2010. All clinical material sent to the
laboratory was processed and inoculated into MGIT bottles.
All mycobacteria grown were identified with multiplex
PCR. Samples of MTC and all NTM isolates that were
previously differentiated by hsp65/IS6110 multiplex PCR
were identified using PRA-PCR.
Clinical Specimens – The specimens were processed
according to standard procedures already in use at the
laboratory (13). All materials were handled in a class II type
B2 laminar flow biological safety cabinet.
Culture – Potentially contaminated specimens were
processed by the modified Petroff method (13), as recom-
mended by the MGIT manufacturer. Other non-contami-
nated specimens, such as tissue fragments or sterile biologic
fluids, were directly inoculated into culture tubes. All
specimens were processed within 24 hours. Smears were
stained by the Ziehl-Neelsen method. A total of 0.5 mL of
processed specimen was added to a BACTEC MGIT 960
culture tube. For the first part of the study, PNB-
supplemented Lowenstein-Jensen media slants were inocu-
lated with the aid of a loop.
Identification
Multiplex PCR - Mycobacterial DNA was extracted from
MGIT culture media by centrifuging 0.5 mL of the liquid
culture media. The resulting pellet was resuspended in
sterile distilled water. The suspension was then heated once
at 80 C˚ for 20 min. Multiplex primers were designed to
amplify sequences of both the hsp65 gene and the IS6110
repetitive element. The primers used in the study were the
following: TB11 (hsp65) 5’-ACCAACGATGGTGTGTCCAT-
3’; TB12 (hsp65) 5’-CTTGTCGAACCGCATACCCT-3’;
TB284 (IS6110) 5’-GGACAACGCCGAATTGCG-3’; and
TB850 (IS6110) 5’-TAGGCGTCGGTGACAAAGGCCAC-3’.
Amplification was performed in a DNA thermal cycler
(GeneAmp PCR 9600; Perkin-Elmer, USA). A 5 mL aliquot of
each DNA sample was used in a total volume of 50 mL PCR
mixture containing 10 mM Tris-HCl (pH 8.8), 50 mM KCl,
1.5 mM MgCl2, 0.1% Triton X-100, 0.2 mM dNTPs, optimal
amounts of primers (12.5 - 25.0 pmol), and 1 U of Taq DNA
polymerase. The multiplex PCR conditions were optimized
as follows: one cycle of denaturation at 95 C˚ for 3 min; 30
cycles consisting of denaturation at 95 C˚ for 20 sec,
annealing at 65 C˚ for 30 sec, and extension at 72 C˚ for
30 sec; and a final cycle of extension at 72 C˚ for 7 min.
Electrophoretic separation of each PCR product (10 mL) was
performed in 2% agarose gel slabs in Tris-borate buffer
[0.56TBE; 0.04 M Tris-borate (pH 8.4), 1 mM EDTA] at
100 V for 30 min. The gels were stained with SYBR Green
(Molecular Probes, Oregon, USA). Reference strains were
run as positive controls (M. tuberculosis H37Rv; M. avium),
and deionized water was used as the negative control. For
comparison of product lengths, 1 mg of 100 bp ladder (Bio-
Rad, USA) was used as a molecular size marker.
PRA-PCR - PCR restriction enzyme analysis of the hsp65
gene (PRA-hsp65) was performed according to previous
reports (14,15). Briefly, an aliquot (5 mL) of each template
DNA was used in 50 mL of PCR mixture containing 10 mM
Tris-HCl (pH 8.8), 50 mM KCl, 1.5 mM MgCl2, 0.1% Triton
X-100, 0.2 mM dNTPs, 12.5 pmol of each primer (TB11 and
TB12), and 2 U of DNA polymerase. The amplification was
performed as follows: one cycle of denaturation at 95 C˚ for
5 min; 45 cycles consisting of denaturation at 94 C˚ for 1 min,
annealing at 62 C˚ for 1 min, and extension at 72 C˚ for 1 min;
and a final cycle of extension at 72 C˚ for 7 min. For BstEII
(Promega, USA) and HaeIII (Promega, USA) enzyme
digestions, 10 mL of each PCR product was added to a
mixture containing 1 mL (20 U) of each enzyme, 3 mL of
restriction buffer, and 16 mL of deionized water. The
mixture was incubated for 60 min at 60 C˚ for BstEII enzyme
digestion and 37 C˚ for HaeIII enzyme digestion. The
electrophoretic separation of digested products was per-
formed for 60 min at 100 V on 3% agarose gel slabs, which
were imaged under UV light after staining with SYBR Green
(Molecular Probes, Oregon, USA). Isolates were identified
using the PRA algorithm as described previously.
PNB was incorporated into LJ medium or BACTEC
MGIT960 7H9 medium to a final concentration of 500 mg/
mL (16). Control growth tubes contained plain LJ medium
and BACTEC MGIT960 7H9 medium without inhibitory
substances. Inocula were prepared from cultures grown on
Lo¨wenstein-Jensen medium. A few colonies were emulsi-
fied in flasks containing glass beads and 2 mL of sterile
distilled water, allowing the turbidity to be greater than the
McFarland scale N˚ 1 standard. The resulting suspension
was left to stand for 15 min to allow larger clumps to settle;
1 mL of the supernatant was then transferred to another
tube, in which the turbidity level was adjusted to McFarland
scale N˚ 1. This bacterial suspension was used as the
working suspension.
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The NAP test was performed in a BACTEC460 radio-
metric device. The isolate was incubated into 12B bottles to a
growth index (GI) of 50 to 100. An aliquot of 1 mL was then
transferred to a new 12B bottle (BACTEC460-radiometric)
containing an impregnated disk with 5 mg of NAP. The GI of
both bottles was recorded and compared every day for the
next 6-7 days.
& RESULTS
Assessment of hsp65/IS6110 multiplex PCR with pre-
viously identified Mycobacterium strains - This part of the
study was designed to compare traditional identification
tests with hsp65/IS6110 multiplex PCR. The hsp65 and
IS6110 sequences were easily and specifically amplified
from DNA extracted with heat lysis from MGIT liquid
culture. Identification with multiplex PCR was simple and
more convenient than other tests conducted in this study,
which demanded more time and more expensive materials.
Initially, no amplification was obtained when we tried to
perform PCR with crude lysates from MGIT aliquots.
However, amplification was successful when the lysates
were centrifuged and the resulting pellet resuspended in
distilled sterile water.
There was 100% agreement between identification with
PNB using either LJ media or MGIT and hsp65/IS6110
multiplex PCR. There was no difference between strains
grown in LJ media and MGIT. The NAP test misidentified 6
cases. The results were consistent among all NTM strains
and MTC strains tested (Table 1).
Application of hsp65/IS6110 multiplex PCR in routine
settings - During the study period, 8,790 clinical specimens
were consecutively received for culture, and 476 isolates
were grown. All positive bottles were enrolled in the study
and submitted to identification with hsp65/IS6110 multi-
plex PCR. In total, 367 (77%) isolates were identified as M.
tuberculosis complex, and 109 (23%) were identified as NTM.
For 19 isolates, amplification was not possible, or multiple
bands were obtained (Table 2). Figure 1 shows the
amplification products of some isolates. A total (n = 130) of
46 MTC isolates and 84 NTM, as identified by multiplex
PCR, were identified using PRA-PCR. Respiratory secre-
tions, sputum and broncho-alveolar lavage were the main
sources of the isolates. M. tuberculosis was recovered from
the sputum, lymph nodes, pleural fluid, urine, and skin.
NTM were isolated from the sputum, blood, bone marrow,
pleural fluid, gastric lavage, broncho-alveolar lavage, feces,
and lymph nodes (Table 3).
There was 100% agreement between multiplex PCR and
PRA-PCR in the samples studied. All strains that were
previously identified as M. tuberculosis or NTM were
confirmed by the reference test. Among NTM, 19 different
species were identified, primarily M. avium as expected, but
other potentially pathogenic species were frequently
observed, including M. fortuitum, M. abscessus, and M.
kansasii (Table 3). The unusual mycobacteria found in this
study, including M. alvei, M. kubicae, M. sherrisii, and M.
parmense, identified by PRA-PCR, require further confirma-
tion by sequencing.
& DISCUSSION
Mycobacteria isolated in clinical settings require fast
identification. The effective treatment of diseases caused
by such agents differs among species and has to be
instituted promptly. The clinical laboratory is essential in
providing this information. Most isolates involved in
human disease and reported in the literature belong to the
M. tuberculosis complex or MAC, but recently, many other
species have been described in association with hospital
infections or cosmetic procedures (2).
In settings where tuberculosis is a major problem, specific
diagnostic methods for the rapid detection and differentia-
tion of NTM infections from TB are of major clinical
importance. Identification based on the use of chemical
inhibitors of growth, such as PNB, is reliable but still has
disadvantages because it is time consuming, expensive, and
can eventually yield false results, inhibiting M. kansasii and
M. marinum growth (16,17).
When using methods based on mycobacterial genomic
amplification, the choice of the target is fundamental for
species or genus identification studies. Insertion sequence
6110 is exclusively found in members of the M. tuberculosis
complex and has been employed in studies worldwide
(18,19). Eventually, the amplification of this target may yield
false-negative results when performed in some geographical
areas (20) because the copy number of this sequence in M.
tuberculosis isolates varies by up to 25 worldwide. Molecular
Table 1 - Distribution of mycobacterial isolates according to
the identification test performed in the validation study.
Multiplex PCR NAP/BACTEC460 PNB/LJ PNB/MGIT
PRA - PCR MTC NTM MTC NTM MTC NTM MTC NTM
MTC 91 0 85 0 91 0 91 0
NTM 0 26 6 26 0 26 0 26
Total 91 26 91 26 91 26 91 26
NAP/BACTEC460 – NAP added to a 12B bottle; PNB/LJ – PNB added to LJ
media; PNB/MGIT - PNB added to an MGIT bottle. MTC – Mycobacterium
tuberculosis complex. NTM – Non-tuberculous mycobacteria.
Table 2 - Number of culture requests, MTC isolates and
NTM isolates, as identified by multiplex PCR, during the
study period.
Year Culture Requests MTC NTM ND
2009 5262 192 66 11
2010 3528 175 43 8
Total 8790 367 109 19
MTC – Mycobacterium tuberculosis complex. NTM – Non-tuberculous
mycobacteria. ND – Not determined.
Figure 1 - hsp65/IS6110 multiplex PCR. Lane 1 – 100 bp ladder;
lanes 2, 6, and 8 – MTC strains; lanes 3, 4, 5, 7, 9, 10, and 11 –
NTM; lane 12 – M. avium; and lane 13 – M. tuberculosis.
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epidemiology and other identification studies in our region
show the universal presence of this sequence in M.
tuberculosis strains, making it a valuable target for identifi-
cation (21,11).
In this work, two sets of primers targeting IS6110, which
is exclusively found in Mycobacterium tuberculosis complex
members, and the genus-specific hsp65 gene were con-
jugated in a multiplex PCR to differentiate MTC from NTM.
This method proved to be very sensitive and specific when
tested against reference identification methods. The useful-
ness of this multiplex PCR was further evident in a clinical
setting in the analysis of a large number of clinical
specimens; many diverse mycobacterial species, as identi-
fied by PRA-PCR, could be separated from members of the
M. tuberculosis complex. No false-negative results were
obtained. All members of the M. tuberculosis complex
identified by multiplex PCR were confirmed by the
reference method. The same result was also found for
non-tuberculous mycobacteria (NTM). When used in the
routine laboratory setting, the test was very sensitive and
specific, confirming the results of the preliminary study. A
significant number of non-tuberculous mycobacteria were
identified from clinical materials, accounting for 23% of all
isolates. The large number of different species of NTM
observed and the fast communication of these data to the
clinical staff were fundamental for the diagnosis of clinical
cases.
NTM isolates have been reported with an increasing
frequency worldwide. This could be due to widely available
sensitive culture methods and identification techniques,
aging, immunosuppression or the inadequate sterilization
of surgical devices.
A particular geographical distribution of NTM species
has been reported. Rapidly growing mycobacteria (RGM)
are the most frequently isolated mycobacterial group in
Shanghai, as reported by Hong-xiu et al. (22), followed by
MAC strains. MAC is not as frequently isolated in AIDS
patients in Africa compared with other occidental countries
(23,24), where M. fortuitum, M. kansasii, and M. xenopi are
primarily found. The identification of NTM in clinical
specimens from Brazil, mostly from regional reference
laboratories, has been reported (25,26), and M. kansasii, M.
avium complex, M. gordonii, and M. fortuitum are the most
frequently observed. However, these reports are based on
clinical specimens sent to the reference laboratory based on
a distinct strict criterion, not on universally cultivated
material, as we have studied. MAC strains, M. fortuitum,
M. kansasii, and M. abscessus were most frequently isolated
in our work.
The high sensitivity and specificity of the genomic targets
used in this study have also been demonstrated in similar
studies by others. When used to detect and identify
reference strains of M. tuberculosis, M. fortuitum, M.
smegmatis, M. avium, and M. bovis to the complex or genus
level, the specificity and sensitivity of this technique were
high, with detection limits of 0.1 fg of template DNA (11).
The amplification of IS6110 and hsp65 targets was also
specific and sensitive when tested with NTM strains, such
as M. chelonae, M. malmoense, M. avium, M. fortuitum, M.
marinum, and M. kansasii, or MTC members, such as M. bovis
and M. africanum (27).
The convenience of this technique in routine settings
processing a large collection of clinical material was
demonstrated in our work. A method could be established
with the initial application of multiplex PCR to all positive
liquid cultures and the subsequent identification of NTM by
PRA-PCR. The diversity of mycobacterial species found
provided valuable clinical information concerning epide-
miology and the clinical management of NTM infections in
our institution.
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